Czech Republic Pharma Snapshot 2019

Czech Republic’s overall pharma market value increased 5 per cent in 2019, while its units produced decreased by 1 per cent.

 

Made with Visme Presentation Maker

 

The number of clinical trials conducted in the Czech Republic increased in 2017 and fell to a three-year low in 2018.

Made with Visme Presentation Maker

 

These are the top 20 pharma companies in the Czech Republic, ranked by sales for the period between October 2018 and October 2019. Novartis came out on top with annual sales of USD 251.4 million, followed by Sanofi with USD 170.9 million and Roche with USD 149.8 million.

Made with Visme Infographic Maker

Similar Facts and Figures

Latest Report